Onderneming ISR Immune System Regulation Holding AB (publ)
Aandelen
ISR
SE0008212195
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ola Winqvist
CEO | Chief Executive Officer | 58 | 17-09-15 |
Jonas Winqvist
DFI | Director of Finance/CFO | 55 | 01-01-21 |
Johan Sjodahl
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 76 | 01-01-16 | |
Erik Kinnman
BRD | Director/Board Member | 66 | 01-01-22 |
Founder | 77 | 17-09-15 | |
Director/Board Member | 77 | 01-01-22 | |
Director/Board Member | - | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 69 008 951 | 48 981 535 ( 70,98 %) | 0 | 70,98 % |
Bedrijfsgegevens
ISR Immune System Regulation Holding AB
Retzius väg 11
171 65, Solna
+46 7 05 42 79 39
http://www.israb.seSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+24,22% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-14,78% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |